Total knee arthroplasty: analysis shows EXPAREL reduces length of hospital stay and improves discharge status compared to standard analgesic modality

Total knee arthroplasty: analysis shows EXPAREL reduces length of hospital stay and improves discharge status compared to standard analgesic modality
Source:
Medical News Today

Pacira Pharmaceuticals, Inc. has announced results of new data showing that EXPAREL® (bupivacaine liposome injectable suspension) infiltration compared to a standard analgesic regimen in patients undergoing total knee arthroplasty (TKA) significantly decreased the length of hospital stay and increased the likelihood that a patient would be discharged to their home rather than a care facility when released from the hospital.

Read more

Orthopedic Surgery Education American Academy of Orthopaedic Surgeons Arthroscopy Association of North America American Orthopaedic Society for Sports Medicine Arthrex OrthoIllustrated Miami Institute For Joint Reconstruction